Calamos Advisors’s Cartesian Growth Corporation II Warrant RENEW Stock Holding History

Calamos Advisors’s Portfolio RENEW Stock Details RENEW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500,000	Closed	-$31.1K	–	976
2025 Q1	$31.1K	Hold	500,000	–	–	﹤0.01%	848
2024 Q4	$42.5K	Hold	500,000	–	–	﹤0.01%	840
2024 Q3	$32.5K	Hold	500,000	–	–	﹤0.01%	835
2024 Q2	$50.5K	Hold	500,000	–	–	﹤0.01%	826
2024 Q1	$55K	Hold	500,000	–	–	﹤0.01%	819
2023 Q4	$67.5K	Hold	500,000	–	–	﹤0.01%	773
2023 Q3	$85K	Hold	500,000	–	–	﹤0.01%	767
2023 Q2	$95K	Hold	500,000	–	–	﹤0.01%	802
2023 Q1	$90K	Hold	500,000	–	–	﹤0.01%	902
2022 Q4	$106K	Buy	+500,000	New	+$58.7K	﹤0.01%	965

Other funds holding RENEW

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Calamos Advisors's RENEW Position: Q2 2025 in Review

Calamos Advisors sold out of Cartesian Growth Corporation II Warrant (RENEW) in Q2 2025, closing a stake of 500,000 shares — an estimated $31.1K sold.

Calamos Advisors first reported a position in RENEW in Q4 2022 and held it in 10 quarters. The position peaked at $106K in Q4 2022. 2 funds tracked by Wall St. Rank hold RENEW as of Q2 2025.

Calamos Advisors reported no remaining Cartesian Growth Corporation II Warrant position as of Q2 2025 after selling out during the quarter.
Calamos Advisors sold 500,000 Cartesian Growth Corporation II Warrant shares in Q2 2025, an estimated $31.1K.
Calamos Advisors first reported a position in Cartesian Growth Corporation II Warrant in Q4 2022 and held it in 10 quarters.
Calamos Advisors's Cartesian Growth Corporation II Warrant position peaked at $106K in Q4 2022.
2 funds tracked by Wall St. Rank held Cartesian Growth Corporation II Warrant as of Q2 2025.

Based on Calamos Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.